Desktop Site
|
27 Sep 24 | 15:59
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
BSE SENSEX
85,571.85
-264.27
-0.31 %
Corporate Announcement
Security Code
506820
Company
AstraZeneca Pharma India Ltd
Exchange Received Time
23/09/2024 19:15:58
Exchange Disseminated Time
23/09/2024 19:15:58
Time Taken
00:00:00
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015 |
9/23/2024 7:15:58 PM
This is to inform that the Company has received permission for sale and distribution of Durvalumab 120mg/2.4 ml and 500mg/10 ml solution for infusion (Imfinzi) from the Central Drugs Standard Organisation for additional indication. The details of the same is mentioned in the attached letter.
Attachment
<< Back
Recently Viewed